To assess whether virus:tumor:T cell interactions are also observed in human cells, we co-cultured NDV-preinfected SUDHL4 cells with human T cells with or without the bispecific T cell engager (BiTE) Blinatumomab, inducing contact-mediated killing through binding of CD19 on the tumor cells and CD3 on T cells (Fig. 1f). This evidence concerns the gene CD19 and neoplasm.